Revvity, Inc. insider Anita Gonzales reported a change in beneficial ownership of the company’s common stock tied to a transaction dated July 20, 2026. The Form 4, filed on July 22, 2026, indicates that the reported transaction was a sale of Revvity common stock. The filing states that the sale was carried out under a Rule 10b5-1 trading plan adopted by Gonzales on November 7, 2025. Such plans allow company insiders to establish prearranged trading instructions at a time when they are not in possession of material nonpublic information, providing an affirmative defense against allegations that later trades were made on inside information. The document identifies the reporting person as Anita Gonzales and the issuer as Revvity, Inc., ticker RVTY. The securities involved were common stock. However, the text provided does not include the transaction table that would normally show the number of shares sold, the sale price or price range, the transaction code, or Gonzales’s beneficial ownership after the sale. The filing was signed on Gonzales’s behalf by John L. Healy under power of attorney on July 22, 2026. While the filing confirms an insider stock sale under a prearranged 10b5-1 plan, the absence of share count, price, and post-transaction ownership details limits the ability to assess the size or financial significance of the transaction.
Stock detail
Revvity (RVTY) stock price, chart, and key data
View Revvity stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Revvity
RVTY · XNYS
-$0.09 (-0.08%) past day
$110.84
After hours $108.29 (+0.20%)
Key metrics
Financials
Quarterly revenue, profitability, and balance-sheet snapshot
Dividend
Past Dividend Performance
$0.07
$0.07
$0.07
Annual Dividend Yield
0.25%
Dividend
$0.07 / Stock
Frequency
Quarterly Payment
Day range
$106.96 - $114.00
Close price
$108.07
Market cap
$12.1B
P/E ratio
54.33
About the company
Revvity, Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Ro Khanna
democrat · House · CA-17
- Buy$1,001 / $8,001 / $15,000
- Sell$1,000 / $8,000 / $15,000
#2Gilbert Cisneros
democrat · House · CA-31
- Buy$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
#3Ro Khanna
democrat · House · CA-17
- Buy$1,000 / $8,000 / $15,000
#4April Delaney
democrat · House · MD-6
#5Donald J Trump
republican · Executive
#6Lisa McClain
republican · House · MI-9
- Sell$1,001 / $8,001 / $15,000
- Buy$1,001 / $8,001 / $15,000
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app